Display options
Cite
Goyal C, Goyal V, Naqvi WM. Goyal-Naqvi Syndrome (Concurrent Trisomy 10p and Terminal 14q Deletion): A Review of the Literature. Cureus. 2021;13(7):e16652doi: 10.7759/cureus.16652.
Goyal, C., Goyal, V., & Naqvi, W. M. (2021). Goyal-Naqvi Syndrome (Concurrent Trisomy 10p and Terminal 14q Deletion): A Review of the Literature. Cureus, 13(7), e16652. https://doi.org/10.7759/cureus.16652
Goyal, Chanan, et al. "Goyal-Naqvi Syndrome (Concurrent Trisomy 10p and Terminal 14q Deletion): A Review of the Literature." Cureus vol. 13,7 (2021): e16652. doi: https://doi.org/10.7759/cureus.16652
Goyal C, Goyal V, Naqvi WM. Goyal-Naqvi Syndrome (Concurrent Trisomy 10p and Terminal 14q Deletion): A Review of the Literature. Cureus. 2021 Jul 26;13(7):e16652. doi: 10.7759/cureus.16652. eCollection 2021 Jul. PMID: 34513343; PMCID: PMC8412206.
Copy Download .nbib Format: NLM
Share it on

Cureus. 2021 Jul 26;13(7):e16652. doi: 10.7759/cureus.16652. eCollection 2021 Jul.

Goyal-Naqvi Syndrome (Concurrent Trisomy 10p and Terminal 14q Deletion): A Review of the Literature.

Cureus

Chanan Goyal, Vivek Goyal, Waqar M Naqvi

Affiliations

  1. Physiotherapy, Datta Meghe Institute of Medical Sciences, Wardha, IND.
  2. Paediatric Physiotherapy, Government Physiotherapy College, Raipur, IND.
  3. Department of Anesthesiology, Shri Balaji Institute of Medical Science, Raipur, IND.
  4. Community Physiotherapy, Mahatma Gandhi Mission School of Physiotherapy, Aurangabad, IND.
  5. Community Physiotherapy, Mahatma Gandhi Mission Institute of Health Sciences, Navi Mumbai, IND.

PMID: 34513343 PMCID: PMC8412206 DOI: 10.7759/cureus.16652

Abstract

Goyal-Naqvi syndrome (GNS) is a newly documented clinical entity that comprises trisomy 10p and terminal 14q deletion, though trisomy 10p and terminal 14q deletion have been discovered as distinct conditions in 1974 and 1997, respectively. Nevertheless, to date, the total number of reported cases of each of these conditions is estimated to be in double digits. Both manifest as a constellation of features like craniofacial dysmorphism, hypotonia, intellectual impairment and global developmental delay. Characteristic facies include protruded forehead, hypertelorism, epicanthic folds, down slanting palpebral fissures, flat nasal bridge, long philtrum, thin upper lip, carp-shaped mouth, retro-micrognathia and low set ears. Besides, trisomy 10p is strikingly associated with clinodactyly and camptodactyly which aids in clinical diagnosis, apart from other musculoskeletal deformities like hip dysplasia and pes planus. Intersex conditions have been found to commonly co-exist. As other systems also display involvement frequently, trisomy 10p is a discernible multiple congenital anomalies/mental retardation (MCA/MR) syndrome. On the other hand, with terminal 14q deletion, increased risk of certain types of cancer was predicted as specific tumor suppressor genes are lost in the deletion and thus, screening was recommended. Genetic workup using techniques like fluorescence in situ hybridization (FISH), spectral karyotyping (SKY) and chromosomal microarray-based comparative genomic hybridization (CGH) was found to be helpful in diagnosis of trisomy 10p and 14q deletion. Prenatal diagnosis of these conditions has been well documented too. Intrauterine growth retardation has been observed to be related to trisomy 10p. There is a paucity of literature on the management of children diagnosed with trisomy 10p or with terminal 14q deletion. Although management of a child diagnosed with concomitant occurrence of trisomy 10p and terminal 14q deletion by a multidisciplinary approach emphasizing physiotherapeutic intervention has shown remarkable improvement in motor skills, the care of children diagnosed with these genetic aberrations needs further investigation. Documentation of more such cases will help to expand phenotypic spectrum for early identification and to delineate natural history for a life span approach. Early identification and intervention facilitate tapping of the maximum neuroplastic potential for better neurodevelopmental outcomes. We present a review of current literature on this novel syndrome to identify gaps in knowledge to build future research.

Copyright © 2021, Goyal et al.

Keywords: goyal naqvi syndrome; goyal-naqvi syndrome; rare genetic disorder; rare syndrome; terminal 14q deletion; trisomy 10p

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. Am J Med Genet A. 2012 Apr;158A(4):869-76 - PubMed
  2. Eur J Haematol. 1990 Apr;44(4):261-4 - PubMed
  3. Sci Rep. 2020 Oct 19;10(1):17642 - PubMed
  4. Gene. 2013 Mar 1;516(1):132-7 - PubMed
  5. Am J Med Genet A. 2016 Apr;170A(4):1017-22 - PubMed
  6. Mol Syndromol. 2012 Jan;2(2):88-93 - PubMed
  7. Clin Dysmorphol. 2012 Jan;21(1):37-41 - PubMed
  8. J Med Genet. 1990 Apr;27(4):264-6 - PubMed
  9. Hum Genet. 1978 Nov 24;45(1):71-5 - PubMed
  10. Clin Dysmorphol. 2006 Jan;15(1):25-7 - PubMed
  11. Fetal Diagn Ther. 2002 Jul-Aug;17(4):243-6 - PubMed
  12. Am J Med Genet A. 2005 Dec 1;139A(2):146-50 - PubMed
  13. Pan Afr Med J. 2020 Jun 17;36:101 - PubMed
  14. Am J Med Genet. 1996 Oct 28;65(3):197-204 - PubMed
  15. Hum Genet. 1978 Mar 17;41(2):235-41 - PubMed
  16. Hum Genet. 1978 Feb 23;41(1):11-7 - PubMed
  17. Am J Med Genet. 2002 Jun 1;110(1):65-72 - PubMed
  18. Clin Genet. 1974;6(5):408-15 - PubMed
  19. J Med Genet. 2003 Apr;40(4):e47 - PubMed
  20. Hum Genet. 1984;67(2):187-9 - PubMed
  21. Am J Ophthalmol. 1994 Mar 15;117(3):411-3 - PubMed
  22. Am J Med Genet A. 2012 Jul;158A(7):1778-81 - PubMed
  23. Am J Med Genet A. 2017 Dec;173(12):3216-3220 - PubMed
  24. Am J Med Genet. 1983 Jan;14(1):159-67 - PubMed
  25. Pathol Int. 2007 Jan;57(1):37-42 - PubMed
  26. Clin Genet. 1978 Dec;14(6):330-7 - PubMed
  27. Hum Genet. 1979 Sep;50(3):253-8 - PubMed
  28. Ann Hum Genet. 1982 Jan 1;46(1):41-74 - PubMed
  29. Prenat Diagn. 2003 Apr;23(4):356-8 - PubMed
  30. Hum Genet. 1979 Jan 25;46(2):129-34 - PubMed
  31. Cureus. 2020 Aug 9;12(8):e9622 - PubMed
  32. Am J Hum Genet. 1984 Jul;36(4):750-9 - PubMed
  33. Humangenetik. 1975 Sep 10;29(2):141-4 - PubMed
  34. Eur J Hum Genet. 2008 Jun;16(6):680-7 - PubMed
  35. Ann Genet. 2000 Jan-Mar;43(1):45-50 - PubMed
  36. Eur J Pediatr. 1982 Oct;139(2):153-7 - PubMed
  37. Humangenetik. 1974;23(3):163-72 - PubMed
  38. Taiwan J Obstet Gynecol. 2013 Sep;52(3):401-6 - PubMed
  39. Am J Med Genet A. 2009 Dec;149A(12):2768-74 - PubMed
  40. Clin Genet. 1999 May;55(5):367-71 - PubMed
  41. Hum Genet. 1977 Mar 14;35(3):353-6 - PubMed
  42. Am J Med Genet A. 2009 May;149A(5):1012-8 - PubMed
  43. Cureus. 2021 Jun 5;13(6):e15459 - PubMed
  44. Cancer Discov. 2011 Aug;1(3):222-35 - PubMed
  45. Eur J Pediatr. 1977 Oct 12;126(3):109-25 - PubMed
  46. Pediatr Neurol. 2007 Jul;37(1):51-4 - PubMed
  47. Am J Med Genet A. 2006 Nov 1;140(21):2324-9 - PubMed
  48. J Med Genet. 1975 Dec;12(4):412-4 - PubMed
  49. Taiwan J Obstet Gynecol. 2020 Sep;59(5):766-769 - PubMed
  50. Am J Med Genet. 2001 Sep 1;102(4):379-82 - PubMed
  51. J Med Genet. 1997 Jun;34(6):515-7 - PubMed
  52. Clin Genet. 1996 Nov;50(5):417-21 - PubMed
  53. Clin Genet. 1983 Jul;24(1):50-3 - PubMed
  54. Neuropathology. 2018 Feb;38(1):22-33 - PubMed
  55. Ann Genet. 1975 Mar;18(1):5-11 - PubMed
  56. Gene. 2013 Feb 25;515(2):439-43 - PubMed
  57. Eur J Med Genet. 2020 Apr;63(4):103776 - PubMed
  58. Hum Genet. 1979;50(1):45-9 - PubMed
  59. Eur J Med Genet. 2006 Sep-Oct;49(5):402-13 - PubMed
  60. Ann Genet. 1976 Mar;19(1):57-60 - PubMed

Publication Types